Treating asymptomatic bone metastases in patients with lung cancer with denosumab can improve QOL

被引：0
|
作者：
Leonard, P. C. [1 ]
Wright, P. [2 ]
Kantilal, K. [3 ]
机构：
[1] Whittington Hlth, Canc Serv Oncol, London, England
[2] Whittington Hlth, Med, London, England
[3] Whittington Hlth, Pharm, London, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
145
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [21] Incidence and consequences of bone metastases in lung cancer patients
    Kuchuk, Michael
    Addison, Christina L.
    Clemons, Mark
    Kuchuk, Iryna
    Wheatley-Price, Paul
    JOURNAL OF BONE ONCOLOGY, 2013, 2 (01) : 22 - 29
  • [22] The risk factors of bone metastases in patients with lung cancer
    Zhou, Yang
    Yu, Qing-Fu
    Peng, Ai-Fen
    Tong, Wei-Lai
    Liu, Jia-Ming
    Liu, Zhi-Li
    SCIENTIFIC REPORTS, 2017, 7
  • [23] Targeted treatments of bone metastases in patients with lung cancer
    Hirsh, Vera
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [24] Financial impact of coverage for zoledronic acid and denosumab in cancer patients with bone metastases.
    Russell, M. W.
    Bell, M. J.
    Namjoshi, M.
    Miller, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Pharmacoeconomic evaluation of denosumab for the treatment of bone metastases in patients with advanced breast cancer in Canada
    Habib, M. J.
    Risebrough, N.
    Moore, P.
    Kendall, R.
    Li, C. M.
    Goeree, R.
    CANCER RESEARCH, 2013, 73
  • [26] Usefulness of bone markers for detection of bone metastases in lung cancer patients
    Alatas, F
    Alatas, Ö
    Metintas, M
    Çolak, Ö
    Erginel, S
    Harmanci, E
    CLINICAL BIOCHEMISTRY, 2002, 35 (04) : 293 - 296
  • [27] Castration Resistant Prostate Cancer: Denosumab prevents bone metastases
    Kriegeskorte, Volker
    AKTUELLE UROLOGIE, 2011, 42 (05) : 281 - 281
  • [28] Management of bone metastases in refractory prostate cancer - role of denosumab
    Paller, Channing J.
    Carducci, Michael A.
    Philips, George K.
    CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 363 - 371
  • [29] The cost of treating skeletal-related events in patients with bone metastases secondary to breast, lung, or prostate cancer
    Barber, B.
    Oglesby, A.
    Lage, M. J.
    Harrison, D. J.
    Jun, S.
    VALUE IN HEALTH, 2008, 11 (03) : A69 - A69
  • [30] Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases
    Dupont, Jolan
    Appermans, Wesley
    Dejaeger, Marian
    Wauters, Isabelle
    Laurent, Michael R.
    Gielen, Evelien
    BONE REPORTS, 2022, 16
12345